Medibio raises $14M for tech that helps diagnose mental-health disorders

Medibio Ltd., which develops technology that helps diagnose mental-health conditions, has raised nearly $14 million through a private placement as it prepares to double its Twin Cities staff. The company plans to put the funding toward preparing for a product launch, plus technology testing and development. Medibio’s investors include Fidelity Investments, which has a nearly 11 percent stake in the company, plus Australian investment firms IFM Investors and Regal FM. Medibio is base d in Australia,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news